Yun Bo Hyon, Kim Sunghoon, Chon Seung Joo, Kim Ga Hee, Choi Young Sik, Cho SiHyun, Lee Byung Seok, Seo Seok Kyo
Department of Obstetrics and Gynecology, Severance Hospital, Yonsei University College of Medicine Seoul, Republic of Korea.
Institute of Women's Life Medical Science, Yonsei University College of Medicine Seoul, Republic of Korea.
Am J Transl Res. 2021 Mar 15;13(3):1400-1410. eCollection 2021.
To investigate whether high-mobility group box-1 induces cell proliferation, invasion and mediates inflammation in ectopic human endometrial stromal cells through Toll-like receptor 4.
Ectopic endometrial specimens were retrieved from patients with ovarian endometrioma having laparoscopy. Ectopic HESCs were treated with HO and recombinant HMGB-1 to induce oxidative stress. The effect of oxidative stress on cell proliferation and invasion was demonstrated. Receptors for HMGB-1 in NF-κB pathway (TLR4, RAGE), angiogenic molecule (VEGF), adhesion molecules (ICAM-1, E-cadherin), and inflammatory cytokines were measured simultaneously to the oxidative stress.
Ectopic HESCs showed markedly decreased cell viability with the increased release of HMGB-1 following treatment with HO. When ectopic HESCs were stressed by rHMGB-1, cell proliferation and cell migration numbers increased significantly in a dose-dependent manner. Increased TLR4 and RAGE mRNA and protein expression levels were noted to rHMGB-1 treatment in a dose-dependent manner. VEGF synthesis was also increased by rHMGB-1 treatment. The gene expression of ICAM-1 was upregulated, whereas that of E-cadherin was downregulated with rHMGB-1 treatment. Interleukin-6, IL-1β, tumor necrosis factor-alpha, and IL-10 were increased significantly by rHMGB-1 treatment. Inversely, after transfection of small interfering RNA against TLR4, rHMGB treatment resulted in decreased cell proliferation and invasion.
HMGB-1 activates the NF-κB pathway via TLR4 to increase cell proliferation, invasion, and the production of various inflammatory markers in HESCs. Thus, HMGB-1, TLR4, and NF-κB may represent potential therapeutic targets for the treatment of endometriosis.
研究高迁移率族蛋白B1(HMGB-1)是否通过Toll样受体4(TLR4)诱导人异位子宫内膜间质细胞增殖、侵袭并介导炎症反应。
从接受腹腔镜手术的卵巢子宫内膜异位囊肿患者中获取异位子宫内膜标本。用HO和重组HMGB-1处理异位人子宫内膜间质细胞(HESCs)以诱导氧化应激。证实氧化应激对细胞增殖和侵袭的影响。在氧化应激的同时,检测NF-κB途径中HMGB-1的受体(TLR4、RAGE)、血管生成分子(VEGF)、黏附分子(ICAM-1、E-钙黏蛋白)和炎性细胞因子。
HO处理后,异位HESCs的细胞活力显著降低,HMGB-1释放增加。当用重组HMGB-1(rHMGB-1)对异位HESCs施加应激时,细胞增殖和细胞迁移数量呈剂量依赖性显著增加。rHMGB-1处理后,TLR4和RAGE的mRNA及蛋白表达水平呈剂量依赖性增加。rHMGB-1处理也增加了VEGF的合成。rHMGB-1处理使ICAM-1的基因表达上调,而E-钙黏蛋白的基因表达下调。rHMGB-1处理显著增加了白细胞介素-6、IL-1β、肿瘤坏死因子-α和IL-10。相反,转染针对TLR4的小干扰RNA后,rHMGB处理导致细胞增殖和侵袭减少。
HMGB-1通过TLR4激活NF-κB途径,以增加HESCs的细胞增殖、侵袭及多种炎性标志物的产生。因此,HMGB-1、TLR4和NF-κB可能是治疗子宫内膜异位症的潜在治疗靶点。